Chitosan, a drug carrier for the 21st century: A review

S.T.P. Pharma Sciences

Volumn 10, Issue 1, 2000, Pages 5-22

  Paul, W ^a   Sharma, C P ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Chitosan; Drug delivery; Films; Gels; Implants; Microspheres; Nasal administration; Ocular administration; Pharmaceutics; Toxicity; Transdermal delivery systems

Indexed keywords

BIOMATERIAL; CHITOSAN; DRUG CARRIER;

ARTIFICIAL SKIN; BIOCOMPATIBILITY; BIODEGRADATION; DRUG DELIVERY SYSTEM; HEMODIALYSIS; HEMOSTASIS; REVIEW; WOUND DRESSING;

EID: 0034005095     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (198)

1. BRACONNOT H. - Sur la nature des champignons. - Ann. Chi. Phys., 79, 265-304, 1811.
2. MUZZARELLI R.A.A. - Stereochemistry and physical characteristics. - In: Chitin, Pergamon Press, Oxford, 1977, pp. 45-86.
3. ROUGET C. - Des substances amylacées dans le tissu des animaux, spécialement les articulés (chitine). - Comp. Rend., 48, 792-795, 1859.
4. HOPPE-SEYLER F. - Ueber chitin und zellulose. - Ber. Deut. Chem. Gesell., 27, 3329-3331, 1894.
5. CHANDY T. and SHARMA C.P. - Chitosan as a biomaterial. -Biomater. Artif. Cells Artif. Organs, 8, 1-24, 1990.
6. SAVAGE P. - In : Chitin: Key to Low-Cost, Plentiful Biopolymers. - Technical Insights Inc., 1995.
7. INOUYE K., MACHIDA Y., SANNAN T. and NAGAI T. - Bouyant sustained release tablets based on chitosan. - Drug Des. Deliv., 2, 165-175, 1988.
8. SHETH P.R. and TOSSOUNIAN J. - The hydrodynamically balanced delivery system for oral use. - Drug Dev. Ind. Pharm., 10, 313-339, 1984.
9. SAWAYANAGI Y., NAMBU N. and NAGAI T. - Directly compressed tablets containing chitin and chitosan in addition to lactose or potato starch. - Chem. Pharm. Bull., 30, 2935-2940, 1982.
10. SAWAYANAGI Y., NAMBU N. and NAGAI T. - Directly compressed tablets containing chitin and chitosan in addition to mannitol. - Chem. Pharm. Bull., 30, 4216-4218, 1982.
11. SAWAYANAGI Y., NAMBU N. and NAGAI T. - Use of chitosan for sustained release preparation of water-soluble drugs. -Chem. Pharm. Bull., 30, 4213-4215, 1982.
12. CHEIN Y.W. - Potential developments and new approaches in oral controlled release drug delivery system. - Drug Dev. Ind. Pharm., 9, 1291-1330, 1983.
13. KAWASHIMA Y., HANDA T., KASAI A., TAKENAKA H. and LIN S.Y. - The effects of thickness and hardness of the coating film on the drug release rate of theophylline granules coated with chitosan-sodium tripolyphosphate complex. - Chem. Pharm. Bull., 33, 2469-2474, 1985.
14. MIYAZAKI S., ISHII K. and NADAI T. - The use of chitin and chitosan as drug carriers. - Chem. Pharm. Bull., 29, 3067-3069, 1981.
15. SHIRAISHI S., ARAHIRA M., IMAI T. and OTAGIRI M. -Enhancement of dissolution rates of several drugs by low molecular weight chitosan and alginate. - Chem. Pharm. Bull., 38, 185-187, 1990.
16. SAWAYANAGI Y., NAMBU N. and NAGAI T. - Dissolution properties and bioavailability of phenytoin from ground mixtures with chitin and chitosan. - Chem. Pharm. Bull., 31, 2062-2068, 1983.
17. SAWAYANAGI Y., NAMBU N. and NAGAI T. - Enhancement of dissolution properties of griseofulvin from ground mixtures with chitin or chitosan. - Chem. Pharm. Bull., 30, 4454-4467, 1982.
18. SAWAYANAGI Y., NAMBU N. and NAGAI T. - Enhancement of dissolution properties of prednisolone from ground mixtures with chitin or chitosan. - Chem. Pharm. Bull., 31, 2507-2509, 1983.
19. ACARTöRK F., SENCAN A. and ÄELEBI N. - Enhancement of the dissolution of spironolactone with chitosan and low molecular weight gelatin. - STP Pharma Sci., 3, 369-373, 1993.
20. ACARTöRK F., SENCAN A. and ÄELEBI N. - Evaluation of the effect of low molecular weight chitosan on the solubility and dissolution characteristics of spironolactone. - Pharnazie, 48, 605-607, 1993.
21. LEHR C.M., BOUWSTRA J.A., SCHACHT E.H. and JUNGINGER H.E. - In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. - Int. J. Pharm., 78, 43-48, 1992.
22. ROBERTS G.A.F. - In: Chitin chemistry. - Mac Millan Press, Houndmills, 1992, pp. 1-25.
23. MUZZARELLI R., BALDASSARE V., CONTI F., FERRARA F., BIAGINI G., GAZZANELLI G. and VASI V. - Biological activity of chitosan: ultrastructure study. - Biomaterials, 9, 247-252, 1988.
24. KNAPCZYK J., KR WCZYNSKI L., SCHENK D. and LIBER Z. - Pharmaceutical dosage forms with chitosan - In: Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, G. Skjak-Braek, T. Anthonsen and P. Sandford Eds., Elsevier Applied Science, London, 1989, pp. 665-670.
25. HILLYARD I.W., DOCZI J. and KIERNAN P.B. - Antacid and antiulcer properties of the polysaccharide chitosan. - Proc. Soc. Exp. Biol. Med., 115, 1108-1112, 1964.
26. HOU W.M., MIYAZAKI S., TAKADA M. and KOMAI T. - Sustained release of indomethacin from chitosan granules. - Chem. Pharm. Bull., 33, 3986-3992, 1985.
27. SAWAYANAGI Y., NAMBU N. and NAGAI T. - Permeation of drugs through chitosan membrane. - Chem. Pharm. Bull., 30, 3297-3301, 1982.
28. KNAPCZYK J., KROWCZYNSKI L., KRZEK J., BRZESKI M., NURNBERG E., SCHENK D. and STRUSZCZYK H. -Requirements of chitosan for pharmaceutical and biomedical applications. - In: Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications., Elsevier Science, London, 1989, pp. 757-764.
29. MCCURDY J.D. - FDA and the use of chitin and chitosan derivative. - In: Advances in Chitin and Chitosan., Elsevier Applied Science, London, 1992, pp. 659-662.
30. ORMROD D.J., HOLMES C.C. and MILLER T.E. - Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. - Atherosclerosis, 138, 329-334, 1998.
31. TORZSAS T.L., KENDALL C.W., SUGANO M., IWAMOTO Y. and RAO A.V. - The influence of high and low molecular weight chitosan on colonic cell proliferation and aberrant crypt foci development in CF1 mice. - Food Chem. Toxicol., 34, 73-77, 1996.
32. ARAI K., KINUMAKI T. and FUJITA T. - Toxicity of chitosan. -Bull. Tokai. Reg. Fish. Res. Lab., 56, 89-94, 1968.
33. YAGI M., KATO S., NISHITOBA T., SATO H., KOBAYASHI N., IINUMA N. and NAGANO N. - Effects of chitosan-coated dialdehyde cellulose, a newly developed oral adsorbent, on glomerulonephritis induced by anti-Thy-1 antibody in rats. -Nephron., 78, 433-439, 1998.
34. MIURA T., USAMI M., TSUURA Y., ISHIDA H. and SEINO Y. - Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. - Biol. Pharm. Bull., 18, 1623-1625, 1995.
35. CHANDA J., KURIBAYASHI R. and ABE T. - Use of the glutaraldehyde-chitosan-treated porcine pericardium as a pericardial substitute. - Biomaterials, 17, 1087-1091, 1996.
36. KURIBAYASHI R., CHANDA J. and ABE T. - Efficacy of the chitosan posttreatment in calcification prevention of the glutaraldehyde-treated porcine aortic noncoronary cusp implanted in the right ventricular outflow tract in dogs. - Artif. Organs, 20, 761-766, 1996.
37. JAMEELA S.R., MISRA A. and JAYAKRISHNAN A. - Cross-linked chitosan microspheres as carriers for prolonged delivery of macromoleculardrugs. - J. Biomater. Sci. Polym. Ed., 6, 621 -632, 1994.
38. OHE T. - Antigenotoxic activities of chitin and chitosan as assayed by sister chromatid exchange. - Sci. Total Environ., 181, 1-5, 1996.
39. RAO S.B. and SHARMA C.P. - Use of chitosa n as a biomaterial: studies on its safety and hemostatic potential. - J. Biomed. Mater. Res., 34, 21-28, 1997.
40. TANAKA Y., TANIOKA S., TANAKA M., TANIGAWA T., KITAMURA Y., MINAMI S., OKAMOTO Y., MIYASHITA M. and NANNO M. - Effects of chitin and chitosan particles on BALB/c mice by oral and parenteral administration. - Biomaterials, 18, 591-595, 1997.
41. SZYMONOWICZ M., PALUCH D., MISTERKA S., STANISZEWSKA-KUS J. and MAJDA J. - Changes in the level of selected laboratory parameters in blood after implantation of chitosan fibers. - Polim. Med., 27, 17-37, 1997.
42. JING S.B., LI L., JI D., TAKIGUCHI Y. and YAMAGUCHI T. -Effect of chitosan in renal function in patients with chronic renal failure. - J. Pharm. Pharmacol., 49, 721-723, 1997.
43. INOUYE K., MACHIDA Y. and NAGAI T. - Sustained release tablets based on chitosan and carboxymethylcellulose sodium. - Drug Des. Deliv., 1, 297-305, 1987.
44. MIYAZAKI S. NAKAYAMA A., ODA M., TAKADA M. and ATTWOOD D. - Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. - Biol. Pharm. Bull., 17, 745-747, 1994.
45. YAO T., YAMADA M., YAMAHARA H. and YOSHIDA M. -Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force. - Chem. Pharm. Bull., 45, 1510-1514, 1997.
46. INOUYE K., MACHIDA Y., SANNAN T. and NAGAI T. - Buoyant sustained release granules based on chitosan. - Drug Des. Del., 4, 55-67, 1989.
47. MIYAZAKI S., YAMAGUCHI H., YOKOUCHI C., TAKADA M. and HOU W.M. - Sustained release of indomethacin from chitosan granules in beagle dogs. - J. Pharm. Pharmacol., 40, 642-643, 1988.
48. SHIRAISHI S., IMAI T. and OTAGIRI M. - Controlled release of indomethacin by chitosan polyelectrolyte complex: optimization and in vivo/in vitro evaluation. - J. Control. Rel., 25, 217-225, 1993.
49. LEE B.J., CHOE J.S. and KIM C.K. - Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. - J. Microencapsul., 15, 775-787, 1998.
50. RAMDAS M., PAUL W. and SHARMA C.P. - Lipoinsulin loaded alginate-chitosan system: oral delivery. - In : Proceedings of International Conference, Polymers 99, IIT Delhi, January 12-15, 1999, pp. 835-838.
51. TAKEUCHI H., YAMAMOTO H., NIWA T., HINO T. and KAWASHIMA Y. - Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. - Pharm. Res., 13, 896-901, 1996.
52. TOZAKI H., KOMOIKE J., TADA C., MARUYAMA T., TERABE A., SUZUKI T., YAMAMOTO A. and MURANISHI S. - Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. - J. Pharm. Sci., 86, 1016-1021, 1997.
53. MIEKKA S.I., JAMESON T., SINGH M., WOOLVERTON C., LIN H.M., KRAJCIK R., MACPHEE M. and DROHAN W.N. -Novel delivery systems for coagulation proteins. - Haemophilia, 4, 436-442, 1998.
54. TASKER R.A., ROSS S.J., DOHOO S.E. and ELSON C.M. -Pharmacokinetics of an injectable sustained release formulation of morphine for use in dogs. - J. Vet. Pharmacol. Ther., 20, 362-367, 1997.
55. TASKER R.A., CONNELL B.J., ROSS S.J. and ELSON C.M. -Development of an injectable sustained release formulation of morphine, antinociceptive properties in rats. - Lab. Anim., 32, 270-275, 1998.
56. JAMEELA S.R., KUMARY T.V., LAL A.V. and JAYAKRISHNAN A. - Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. - J. Control. Rel., 52, 17-24, 1998.
57. JAMEELA S.R., LATHA P.G., SUBRAMONIAM A. and JAYAKRISHNAN A. - Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma. - J. Pharm. Pharmacol., 48, 685-688, 1996.
58. WANG Y.M., SHI T.S., PU Y.L., ZHU J.G. and ZHAO Y.L. -Studies on hepatic arterial embolization with cisplatin-chitosan-microspheres in dogs. - Yao. Hsueh. Hsueh. Pao., 30, 891-895, 1995.
59. ICHIKAWA H., ONISHI H., TAKAHATA T., MACHIDA Y. and NAGAI T. - Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine. - Drug Des. Discov., 10, 343-353, 1993.
60. THACHARODI D. and RAO K.P. - Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride. -Biomaterials, 16, 145-148, 1995.
61. THACHARODI D. and RAO K.P. - Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: development and in vitro evaluations. - Biomaterials, 17, 1307-1311, 1996.
62. THACHARODI D. and RAO K.P. - Propranolol hydrochloride release behaviour of cross-linked chitosan membranes. - J. Chem. Technol. Biotechnol., 58, 177-181, 1993.
63. JOHN J. - Formulation, optimization and evaluation of transdermal drug delivery systems of captopril. - M.Pharm. Thesis, University of Kerala, 1994.
64. JOHN J. and SHARMA C.P. - Chitosan, Biomedical applications. - In: Trends in Carbohydrate Chemistry, P.L. Soni Ed., Surya International Publishers, Dehra Dun, 1995, pp. 133-136.
65. BENNY K.J. - Formulation and evaluation of transdermal drug delivery systems of Atenolol. - M. Pharm. Thesis, University of Kerala, 1993.
66. GENTA I., CONTI B., PERUGINI P., PAVANETTO F., SPADARO A. and PUGLISI G. - Bioadhesive microspheres for ophthalmic administration of acyclovir. - J. Pharm. Pharmacol., 49, 737-742, 1997.
67. SKAUGRUD Ø. - Drug delivery systems with alginate and chitosan. - In: Excipients and Delivery Systems for Pharmaceutical Formulations, D. R. Karsa, R.A. Stephenson Eds., Royal Society of Chemistry, Cambridge, 1995, pp. 96-107.
68. HENRIKSEN I., GREEN K.L., SMART J.D., SMISTAB G. and KARLSEN J. - Chitosan-coated liposomes for topical ocular drug administration. - Int. J. Pharm., 145, 231-240, 1996.
69. CALVO P., VILA-JATO J.L. and ALONSO M.J. - Chitosan coated poly-caprolactone nanoparticles as a carrier for indomethacin. - Int. J. Pharm., 153, 41-50, 1997.
70. SCHIPPER N.G., VARUM K.M. and ARTURSSON P. -Chitosans as absorption enhancers for poorly absorbable drugs. 1. Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. - Pharm. Res., 13, 1686-1692, 1996.
71. ASPDEN T.J., ILLUM L. and SKAUGRUD Ø. - The absence of chitosan toxicity when applied to nasal mucosa. - In : Proceedings of the 22nd International Symposium of Controlled Release Bioactive Materials, 1995, pp. 550-551.
72. SCHIPPER N.G., OLSSON S., HOOGSTRAATE J.A., DEBOER A.G., VARUM K.M. and ARTURSSON P. - Chitosans as absorption enhancers for poorly absorbable drugs. 2. Mechanism of absorption enhancement. - Pharm. Res., 14, 923-929, 1997.
73. ARTURSSON P., LINDMARK T., DAVIS S.S. and ILLUM L. -Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). - Pharm. Res., 11, 1358-1361, 1994.
74. KOTZE A.F., THANOU M.M., LUEBETAEN H.L., DE BOER A.G., VERHOEF J.C. and JUNGINGER H.R. - Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2). - J. Pharm. Sci., 88, 253-257, 1999.
75. ASPDEN T.J., MASON J.D.T., JONES N.S., LOWE J., SKAUGRUD Ø. and ILLUM L. - Chitosan as nasal delivery system: the effect of chitosan solutions in vitro and in vivo mucociliary transport rates in human tubinates and volunteers. - J. Pharm. Sci., 86, 509-513, 1997.
76. ILLUM L., FARRAJ N.F. and DAVIS S.S. - Chitosan as a novel nasal delivery system for peptide drugs. - Pharm. Res., 11, 1186-1189, 1994.
77. SOANE R.J., FRIER M., PERKINS A.C., JONES N.S., DAVIS S.S., ILLUM L. - Evaluation of the clearance characteristics of bioadhesive systems in humans. - Int. J. Pharm., 178, 55-65, 1999.
78. GENTA I., COSTANTINI M. and MONTANARI L. - Chitosan microspheres for nasal delivery: effect of cross-linking agents on release characteristics. - Proceedings of the 23rd International Symposium of Controlled Release Bioactive Materials, Kyoto, Japan, 1996, pp. 135-139.
79. JABBAL-GILL I., FISHER A.N., RAPPUOLI R., DAVIS S.S and ILLUM L. - Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice. - Vaccine, 16, 2039-2046, 1998.
80. ILLUM L., DAVIS S.S., PAWULA M., FISHER A.N., BARRETT D.A., FARRAJ N.F. and SHAW P.N. - Nasal administration of morphine-6-glucuronide in sheep, a pharmacokinetic study. -Biopharm. Drug Dispos., 17, 717-724, 1996.
81. VASUDEV S.C., CHANDY T. and SHARMA C.P. - Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis. - Biomaterials, 18, 375-381, 1997.
82. ELCIN Y.M., DIXIT V. and GITNICK G. - Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. - Artif. Cells Blood Substit. Immobil. Biotechnol., 24, 257-271, 1996.
83. CHANDY T., MOHANTY M., JOHN A., RAO S.B., SIVAKUMAR R., SHARMA C.P. and VALIATHAN M.S. - Structural studies on bovine bioprosthetic tissues and their in vivo calcification: prevention via drug delivery. - Biomaterials, 17, 577-585, 1996.
84. SONG Y., ONISHI H., MACHIDA Y. and NAGAI T. - Drug release and antitumor characteristics of N-succinyl-chitosan-mitomycin C as an implant - J. Control. Rel., 42, 93-100, 1996.
85. JAMEELA S.R. and JAYAKRISHNAN A. - Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. - Biomaterials, 16, 769-775, 1995.
86. MACHIDA Y., NAGAI T., ABE M. and SANNAN T. - Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release. - Drug Des. Deliv., 1, 119-130, 1986.
87. NAGAI T. SAWAYANAGI Y. and NAMBU N. - Application of chitin and chitosan to pharmaceutical preparation - In: Chitin, Chitosan and Related Enzymes., J.P. Zikakis Ed., Academic Press, Orlando, 1984, pp. 21-35.
88. MIYAZAKI T., KOMURO T., TOMOTA C. and OKADA S. -Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate. - Eisei. Shikenjo. Hokoku., 108, 95-97, 1990.
89. ACARTöRK F. - Preparation of a prolonged release tablet formulation of diclofenac sodium. Part I. Using chitosan. -Pharmazie, 44, 547-549, 1989.
90. SABINIS S., REGE P. and BLOCK L.H. - Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. - Pharm. Dev. Technol., 2, 243-255, 1997.
91. TAKAYAMA K., HIRATA M., MACHIDA Y., MASADA T., SANNAN T. and NAGAI T. - Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. - Chem. Pharm. Bull., 38, 1993-1997, 1990.
92. YAMOTA C., MIYAZAKI T. and OKADA S. - Sustained release effect of the direct compressed tablets based on chitosan and Na alginate. - Yakugaku Zasshi, 114, 257-263, 1994.
93. BERNKOP-SCHNURCH A. and KRAJICEK M.E. -Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. - J. Control. Rel., 50, 215-223, 1998.
94. BERNKOP-SCHNURCH A. and SCERBE-SAIKO A. - Synthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins. - Pharm. Res., 15, 263-269, 1998.
95. BERNKOP-SCHNURCH A. and PASTA M. - Intestinal peptide and protein delivery: novel bioadhesive drug-carrier matrix shielding from enzymatic attack. - J. Pharm. Sci., 87, 430-434, 1998.
96. BERNKOP-SCHNURCH A., KRAULAND A. and VALENTA C. - Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate. - J. Drug Target., 6, 207-214, 1998.
97. REMUNAN-LOPEZ C., PORTERO A., VILA-JATO J.L. and ALONSO M.J. - Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. - J. Control. Rel., 55, 143-152, 1998.
98. KAWASHIMA Y., LIN S.Y., UEDA M., TAKENAKA H. and ANDO Y. - Direct preparation of solid particulates of aminopyrine-barbital complex (pyrabital) from droplets by a spray drying technique. - J. Pharm. Sci., 72, 514-518, 1983.
99. KAWASHIMA Y., LIN S.Y., KASAI A., HANDA T. and TAKENAKA H. - Preparation of a prolonged release tablet of aspirin with chitosan. - Chem. Pharm. Bull., 33, 2107-2113, 1985.
100. MIYAZAKI S., NAKAYAMA A., ODA M., TAKADA M. and ATTWOOD D. - Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate. - Int. J. Pharm., 118, 257-263, 1995.
101. BODMEIER R., CHEN H.G. and PAERATAKUL O. - A novel approach to the oral delivery of micro- or nanoparticles. -Pharm. Res., 6, 413-417, 1989.
102. WAN L.S.C., LIM L.Y. and SOH B.L. - Drug release from chitosan beads. - STP Pharma Sci., 4, 195-200, 1994.
103. BUGAMELLI F., RAGGI M.A., ORIENTI I. and ZECCHI V. -Controlled insulin release from chitosan microparticles. - Arch. Pharm., 331, 133-138, 1998.
104. MOOREN F.C., BERTHOLD A., DOMSCHKE W. and KREUTER J. - Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers. - Pharm. Res., 15, 58-65, 1998.
105. BERTHOLD A., CREMER K. and KREUTER J. - Preparation and characteristion of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model anti-inflamatory drugs. - J. Control. Rel., 39, 17-25, 1996.
106. LIU X.J., XIE S.S., ZHANG Y.X., ZHANG J.L., ZHANG D., WANG Y.L., NI D., LI D., LU M. and YE Q.T. - Preparation of rotundine-chitosan gelled granules and their drug-release tests. - Yao. Hsueh. Hsueh. Pao., 26, 782-787, 1991.
107. GENTA I., PERUGINI P. and PAVANETTO F. - Different molecular weight chitosan microspheres: influence on drug loading and drug release. - Drug Dev. Ind. Pharm, 24, 779-784, 1998.
108. GIUNCHEDI. P., GENTA I., CONTI B., MUZZARELLI R.A.A. and CONTE U. - Preparation and characterization of ampicillin loaded methylpyrrolidinone chitosan and chitosan microspheres. - Biomaterials, 19, 157-161, 1998.
109. REMUNAN-LOPEZ C., LORENZO-LAMOSA M.L., VILA-JATO J.L. and ALONSO M.J. - Development of new chitosan-cellulose multicore microparticles for controlled drug delivery. - Eur. J. Pharm. Biopharm., 45, 49-56, 1998.
110. RAMDAS M., DILEEP K.J., ANITHA Y., PAUL W. and SHARMA C.P. - Alginate encapsulated bioadhesive chitosan microspheres for intestinal delivery. - J. Biomater. Appl., 13, 290-296, 1999.
111. LORENZO-LAMOSA M.L., REMUNAN-LOPEZ C., VILA-JATO J.L. and ALONSO M.J. - Design of microencapsulated chitosan microspheres for colonic drug delivery. - J. Control. Rel., 52, 109-118, 1998.
112. MI F.L., WONG T.B. and SHYU S.S. - Sustained release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods. - J. Microencapsul., 14, 577-591, 1997.
113. CHANDY T. and SHARMA C.P. - Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. -Biomaterials, 13, 949-952, 1992.
114. CHANDY T. and SHARMA C.P. - Biodegradable chitosan matrix for the controlled release of steroids. - Biomat. Art. Cells Immob. Biotech., 19, 745-760, 1991.
115. CHANDY T. and SHARMA C.P. - Chitosan matrix for oral sustained delivery of ampicillin. - Biomaterials, 14, 939-944, 1993.
116. CDRI Report 73/602. - In vivo evaluation of drug loaded chitosan microspheres. - Central Drug Research Institute, Lucknow, India, 1998.
117. THANOO B.C., SUNNY M.C. and JAYAKRISHNAN A. - Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. - J. Pharm. Pharmacol., 44, 283-286, 1992.
118. NISHIMURA K., NISHIMURA S., SEO H., NISHI N., TOKURA S. and AZUMA I. - Macrophage activation with multiporous beads prepared from partially deacetylated chitin. - J. Biomed. Mater. Res., 20, 1359-1372, 1986.
119. 3+, protamine sulfate and levamisole. - Biomaterials, 11, 718-723, 1990.
120. CHANDY T. and SHARMA C.P. - Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads. - Biomaterials, 17, 61-66, 1996.
121. LYMAN D.J. and KIM S.W. - Interaction at the blood-polymer interface. - Fed. Proc., 30, 658-669, 1971.
122. PATASHNIKS., RABINOVICH L. and GOLOMB G. - Preparation and evaluation of chitosan microspheres containing bisphosphonates. - J. Drug Target., 4, 371-380, 1997.
123. OHYA Y., TAKEI T., KOBAYASHI H. and OUCHI T. - Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. - J. Microencapsul., 10, 1-9, 1993.
124. OUCHI T. and BANBA T. - Fixation of 5-flourouracil to chitosan and its antitumor activity. - Trans. Soc. Biomed., 11, 232-235, 1988.
125. OUCHI T., BANBA T., FUJIMOTO M. and HAM S. - Synthesis and antitumor activity of chitosan carrying 5-FU. - Makromol. Chem., 190, 1817-1825, 1989.
126. AKBU A J. and BERGISADI N. -5-Flourouracil loaded chitosan microspheres: preparation and release characteristics. - J. Microencapsul., 13, 161-168, 1996.
127. HASSAN E.E., PARISH R.C. and GALLO J.M. - Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. - Pharm. Res., 9, 390-397, 1992.
128. HASSAN E.E. and GALLO J.M.-Targeting anticancer drugs to the brian. I. Enhanced brian delivery of oxantrazole following administration in magnetic cationic microspheres. - J. Drug Target., 1, 7-14, 1993.
129. MIWA A., ISHIBE A., NAKANO M., YAMAHIRA T., ITAI S., JINNO S. and KAWAHARA H. - Development of novel chitosan derivatives as micellar carriers of taxol. - Pharm. Res., 15, 1844-1850, 1998.
130. BAYOMI M.A., AL-SUWAYEH S.A., EL-HELW A.M. and MESNAD A.F. - Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. - Pharm. Acta. Helv., 73, 187-192, 1998.
131. PAVANETTO F., GENTA I., CONTI B., MODENA T. and PRUGINI P. - Multiple emulsion o/w/o as preparation method for hydrophobic drug loaded chitosan microspheres. -Proceedings of 10th International Symposium of Microencapsulation, Austin, 1995, pp. 49-51.
132. GOSCONDA S.R. and UPADRASHTA S.M. - Avicel RC-591/chitosan beads by extrusion-spheronisation technology. - Drug Dev. Ind. Pharm., 19, 915-927, 1993.
133. LEE Y.C., YOO Y.M., KIM K.S. and SHIN J.S. - Sustained release of aspirin from chitosan granules. - Pollimo, 14, 342-345, 1990.
134. ILLUM L. - Systemic drug delivery compositions comprising a polycationic substance. - US Patent 5554388, 1996.
135. ILLUM L. - Drug delivery compositions. - US Patent 5744166, 1998.
136. WATTS P.J. and ILLUM L. - Drug delivery compositions containing chitosan or derivative therof having a defined z.potential. - US Patent 5840341, 1998.
137. MITTAL S., COHEN A. and MAYSINGER D. - In vitro effects of brain derived neurotrophic factor released from microspheres. - Neuroreport, 5, 2577-2582, 1994.
138. EL FATTAH E.A., GRANT D.J., GABR K.E. and MESHALI M.M. - Physical characteristics and release behaviour of sulbutamol sulphate beads prepared with different ionic polysaccharides. -Drug Dev. Ind. Pharm., 24, 541-547, 1998.
139. DANGPRASIRT P. and PONGWAI S. - Development of diclofenac sodium controlled release solid dispersion powders and capsules by freeze drying technique using ethylcellulose and chitosan as carriers. - Drug Dev. Ind. Pharm., 24, 947-953, 1998.
140. AL-HELW A.A., AL-ANGARY A.A., MAHROUS G.M. and AL-DARDARI M.M. - Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone. - J. Microencapsul., 15, 373-382, 1998.
141. HUANG R.G., SCHWARTZ J.B. and OFHER C.M. -Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release. - Pharm. Dev. Technol., 4, 107-115, 1999.
142. LI Y.P., MACHIDA T.Y., SANNA T. and NAGAI T. - Preparation of chitosan microspheres containing flourouracil using drug-in-oil' method and its release characteristics. - STP Pharma Sci., 1, 363-368, 1991.
143. ZHANG Y, HOU C and CHEN A. - In vitro experimental study of adriamycin-loaded chitosan drug delivery system. - Chung. Kuo. Hsiu. Fu. Chung. Chien. Wai. Ko. Tsa. Chih., 11, 309-311, 1997.
144. MACHIDA Y. - Development of topical drug delivery systems utilizing polymeric materials. - Yakugaku Zasshi, 113, 356-368, 1993.
145. GENTA I., PAVANETTO F., CONTI B., GIUNCHEDI P. and CONTE V. - Improvement of dexamethasone dissolution rate from spray dried chitosan microspheres. - STP Pharma Sci., 5, 202-207, 1995.
146. MURATA Y., MIYOMOTO E. and KAWASHIMA S. - Additive effect of chondroitin sulphate and chitosan on drug release from calcium induced alginate gel beads. - J. Control. Rel., 38, 101-108, 1996.
147. ACIKGOZ M., KAS H.S., ORMAN M. and HINCAL A.A. -Chitosan microspheres of diclofenac sodium. I. Application of factorial design and evaluation of release kinetics. - J. Microencapsul., 13, 141-159, 1996.
148. AKBU A J. and DURMAZ G. - Preparation and evaluation of crosslinked chitosan microspheres containing furosemide. - Int. J. Pharm., 111, 217-222, 1994.
149. MIYAZAKI S., YAMAGUCHI H., YOKOUCHI C., TAKADA M. and HOU W.M. - Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. - Chem. Pharm. Bull., 36, 4033-4038, 1988.
150. AIEDEH K., GIANASI E., ORIENTI I. and ZECCHI V. - Chitosan microcapsules as controlled release system for insulin. - J. Microencapsul., 14, 567-576, 1997.
151. CHANDY T. and SHARMA C.P. - Oral insulin delivery from lipoinsulin loaded chitosan granules. - Biomater. Living Sys. Interac., 1, 163-169, 1993.
152. SINGH U.V. and UDUPA N. - Methotrexate loaded chitosan and chitin microspheres, in vitro characterization and pharmacokinetics in mice bearing Ehrlich ascites carcinoma. -J. Microencapsul., 15, 581-594, 1998.
153. FILIPOVIC-GRICIC J., BECIREVIC-LACAN M., SKALKO N. and JALSENKA I. - Chitosan microspheres of nifedipine-cyclodextrin inclusion complexes. - Int. J. Pharm., 135, 183-190, 1996.
154. SEZER A.D. and AKBUGA J. - Controlled release of piroxican from chitosan beads. - Int. J. Pharm., 121, 113-116, 1995.
155. LIN S.Y. and LIN P.C. - The influence of sodium bicarbonate and sodium tripolyphosphate and the adding sequence on the formation and dissolution of theophylline chitosan microcapsules. - STP Pharma Sci., 2, 500-505, 1992.
156. CALVO P., REMUNAN-LOPEZ C., VILA-JATO J.L. and ALONSO M.J. - Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. - Pharm. Res., 14, 1431-1436, 1997.
157. CALVO P., REMUNAN-LOPEZ C., VILA-JATO J.L. and ALONSO M. J. - Novel chitosan-polyethylene oxide nanoparticles as protein carriers. - J. Appl. Poly. Sci., 63, 125-132, 1997.
158. EL-SAMALIGY M.S., ROJANASAKUL Y., CHARLTON J.F., WEINSTEIN G.W. and LIM J.K. - Development of ganciclovir nanoparticles for ocular administration. - Drug Deliv., 3, 93-98, 1996.
159. ALONSO M.J., SALVE P., REMUNAN-LOPEZ C. and VILA-JATO J.L. - Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms. - European Patent 0860 166 A1, 1998.
160. TIAN X.X. and GROVES M.J. - Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles. - J. Pharm. Pharmacol., 51, 151-157, 1999.
161. ERBACHER P., ZOU S., BETTINGER T., STEFFAN A.M. and REMY J.S. - Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. -Pharm. Res., 15, 1332-1339, 1998.
162. ROY K., MAO H.Q., HUANG S.K. and LEONG K.W. - Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. -Nat. Med., 5, 387-391, 1999.
163. LEONG K.W., MAO H.Q., TRUONG-LE V.L., ROY K., WALSH S.M. and AUGUST J.T. - DNA-polycation nanospheres as non-viral gene delivery vehicles. - J. Contol. Rel., 53, 183-193, 1998.
164. LEE K.Y., KWON I.C., KIM Y.H., JO W.H. and Jeong S.Y. -Preparation of chitosan self-aggregates as gene deivery system. - J. Contol. Rel., 51, 213-220, 1998.
165. UCHEGBU I.F., SCHATZLEIN A.G., TETLEY L., GRAY A.I., SLUDDEN J., SIDDIQUE S. and MOSHA E. - Polymeric chitosan-based vesicles fordrug delivery. - J. Pharm. Pharmacol., 50, 453-458, 1998.
166. CALVO P., BOUGHABA A.S., APPEL M., FALIAL E., ALONSO M.J. and COUVREUR P. - Oligonucleotide-Chitosan nanoparticles as new gene therapy vector. - Proc. 2nd World Meeting APGI/APV, 111-112, 1998.
167. FRIEDMAN D., SCHWARTZ J. and AMSELEM S. - Bioadhesive emulsion preparations for enhanced drug delivery. - US Patent 5744155, 1998.
168. CALVO P., REMUNAN-LOPEZ C., VILA-JATO J.L. and ALONSO M.J. - Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron-emulsions. - Colloid. Poly. Sci., 275, 45-53, 1997.
169. ALONSO M.J., SALVE P., REMUNAN-LOPEZ C. and VILA-JATO J.L. - Stabilization of colloidal complexes by the formation of ionic lipid-polysaccharide complexes. - European Patent 0771 566 A1, 1997.
170. NEEDLEMAN I.G., SMALES F.C. and MARTIN G.P. - An investigation of bioadhesion for periodontal and oral mucosal drug delivery. - J. Clin. Periodontol., 24, 394-400, 1997.
171. NEEDLEMAN I.G., MARTIN G.P. and SMALES F.C. -Characterisation of bioadhesiveness for periodontal and oral mucosal drug delivery. - J. Clin. Periodontol., 25, 74-82, 1998.
172. BEENA M.S., CHANDY T. and SHARMA C.P. - Heparin immobilized chitosan-poly ethylene glycol interpenetrating network: antithrombogenecity. - Artif. Cells Blood Substit. Immobil. Biotechnol., 23, 175-192, 1995.
173. PATEL M. and AMIJI M.M. - Preparation and characterisation of freeze-dried chitosan-poly (ethylene oxide) hydrogels for site specific antibiotic delivery in stomach. - Pharm. Res., 13, 588-593, 1996.
174. DUMITRIU S., CHORNET E. and VIDAL P. - Polymeric insoluble hydrogels comprising xanthan and chitosan. - US Patent 5620706, 1997.
175. LORENZ D.H. and LEE C.C. - Gels formed by the interaction of polyvinyl pyrrolidone with chitosan derivatives. - US Patent 5420197, 1995.
176. MIYAZAKI S., YAMAGUCHI H., TAKADA M., HOU W.M., TAKEICHI Y. and YASUBUCHI H. - Pharmaceutical applications of biomedical polymers. XXIX. Preliminary study on film dosage form prepared from chitosan for oral drug delivery. - Acta. Pharm. Nord., 2, 401-406, 1990.
177. KANKE M., KATAYAMA H., TSUZUKI S. and KURAMOTO H. - Application of chitin and chitosan to pharmaceutical preparations. I. Film preparation and in vitro evaluation. - Chem. Pharm. Bull., 37, 523-525, 1989.
178. KIM J.H., KIM J.Y., LEE Y.M. and KIM K.Y. - Controlled release of riboflavin and insulin through crosslinked poly (vinyl alcohol)/chitosan blend membrane. - J. Appl. Poly. Sci., 44, 1823-1828, 1992.
179. MACLEOD G.S., COLLETT J.H. and FELL J.T. - The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release. - J. Control. Rel., 58, 303-310, 1999.
180. KAWASHIMA Y., HANDA T., KASAI A., TAKENAKA H., LIN S.Y. and ANDO Y. - Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan. - J. Pharm. Sci., 74, 264-268, 1985.
181. ALEXAKIS T., BOADI D.K., QUONG D., GROBOILLOT A., O'NEILL I., PONCELET D. and NEUFELD R.J. -Microencapsulation of DNA within alginate microspheres and crosslinked chitosan membranes for in vivo application. - Appl. Biochem. Biotechnol., 50, 93-106, 1995.
182. MAYSINGER D., BEREZOVSKAYA O. and FEDOROFF S. -The hematopoietic cytokine colony stimulating factor 1 is also a growth factor in the CNS: (II). Microencapsulated CSF-1 and LM-10 cells as delivery systems. - Exp. Neurol., 141, 47-56, 1996.
183. HARI P.R., CHANDY T. and SHARMA C.P. - Chitosan/calcium alginate beads for oral delivery of insulin. - J. Appl. Poly. Sci., 59, 1795-1801, 1996.
184. HARI P.R., CHANDY T. and SHARMA C.P. - Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. -J. Microencapsul., 13, 319-329, 1996.
185. SEZER A.D. and AKBUGA J. - Release characteristics of chitosan treated alginate beads. I. Sustained release of a macromolecular drug from chitosan treated alginate beads. - J. Microencapsul., 16, 195-203, 1999.
186. POLK A.A., AMSDEN B., YAO K.D., PENG T. and GOOSEN M.F.A. - Controlled release of albumin from chitosan alginate microcapsules. - J. Pharm. Sci., 83, 178-185, 1984.
187. OKHAMAFE A.O., AMSDEN B., CHU W. and GOOSEN M.F.A. - Modulation of protein release from chitosan-alginate microcapsules using the pH sensitive polymer hydroxypropyl methyl-cellulose acetate succinate. - J. Microencapsul., 13, 497-508, 1997.
188. LIU L.S. LIU S.Q., NG S.H., HELLER J. and FROIX M. - The potential application of alginate chitosan porous microspheres loaded with interleukin-2 in tumour immunotherapy. -Proceedings of 22nd International Symposium on Controlled Release Bioactive Materials, Seattle, USA, 1995, pp. 542-543.
189. MURATA Y., MAEDA T., MIYAMOTO E. and KAWASHIMA S. - Preparation of chitosan-reinforced alginate gel beads, pharmaceutics effects of chitosan on gel matrix errosion. - Int. J. Pharm., 96, 139-145, 1993.
190. PAUL W. and SHARMA C.P. - Antibiotic loaded hydroxyapatite osteoconductive implant material - in vitro release studies. - J. Mater. Sci. Letters, 14, 1792-1794, 1995.
191. SUGIMOTO K., YOSHIDA M., YATA T., HIGAKI K. and KIMURA T. - Evaluation of poly (vinyl alcohol) gel spheres containing chitosan as dosage form to control gastro-intestinal transit time of drugs. - Biol. Pharm. Bull., 21, 1202-1206, 1998.
192. VURAL I., KAS H.S and HINCAL A.A. - Indomethacin microspheres. I. Formulation and in vitro evaluation. - Chimica-Oggi, 9, 49-52, 1991.
193. NISHIOKA Y., KYOTANI S., OKAMURA M., MIYAZAKI M., OKAZAKI K., OHNISHI S., YAMAMOTO Y. and ITO K. -Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.-Chem. Pharm. Bull., 38, 2871-2873, 1990.
194. NISHIOKA Y., KYOTANI S., NASUI H., OKAMURA M., MIYAZAKI M., OKAZAKI K., OHNISHI S., YAMAMOTO Y. and ITO K. - Preparation and release characteristics of cisplatin albumin microspheres containing chitin and treated with chitosan. - Chem. Pharm. Bull., 37, 3074-3077, 1989.
195. NISHIYOKA Y., KYOTANI S., OKUMURA M., MIYAZAKI M., SAKAMOTO Y., MORITA M., OKAZAKI K., OHNISHI S., YAMAMOTO Y. and ITO K. - A study of emolizing materials for chemoembolization therapy of hepatocellular carcinoma. Embolic effect of cisplatin albumin microspheres using chitin and chitosan in dogs and changes of cisplatin content in blood and tissue. - Chem. Pharm. Bull., 40, 267-268, 1992.
196. BLOCK L.H., SABNIS S.S. - Methods of creating a unique chitosan and employing the same to form complexes with drugs, delivery of the same within a patient and related dosage form. - US Patent 5830883, 1998.
197. TAKEUCHI H., YAMAMOTO H., NIWA T., HINO T. and KAWASHIMA Y. - Mucoadhesion of polymer-coated liposomes to rat intestine in vitro. - Chem. Pharm. Bull., 42, 1954-1956, 1994.
198. ALAMELU S. and RAO K.P. - Studies on the carboxymethyl chitosan containing liposomes for their stability and controlled release of dapsone. - J. Microencapsul., 8, 505-519, 1991.